Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Vapotherm Inc's Business Segments
Vapotherm Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
13
Largest Segment
Product Revenue
Total Revenue
$ 17
Countrys Reported
1
Revenue Share by Reportable Segment - FY
- Product Revenue87.9%
- US78.9%
- Disposable Product Revenue73.7%
- Product Revenue US70.4%
- Disposable Product Revenue US58.8%
- Capital Equipment Product Revenue14.2%
- Capital Equipment Product Revenue US11.7%
- Service Other8.2%
- Service Other US5.6%
- Lease Revenue Other3.1%
- Lease Revenue Other US2.5%
- Lease Revenue Capital Equipment0.9%
- Lease Revenue Capital Equipment US0.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product Revenue | $ 15 | 87.9% |
| US | $ 13 | 78.9% |
| Disposable Product Revenue | $ 12 | 73.7% |
10 more segments available
Sign in to unlock the full Vapotherm Inc dataset.
Revenue Share by Country - FY
- US78.9%
Revenue by Geographic Country - FY
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 13 | 78.9% |
Revenue by Product & Service Category - FY
- Product Revenue70.4%
- Disposable Product Revenue58.8%
- Capital Equipment Product Revenue11.7%
- Service Other5.6%
- Other Lease Revenue2.5%
- Capital Equipment Lease Revenue0.4%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product Revenue | $ 12 | 70.4% |
| Disposable Product Revenue | $ 10 | 58.8% |
| Capital Equipment Product Revenue | $ 2 | 11.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Vapotherm Inc dataset.
Annual Results
Revenue Share by Reportable Segment - FY
- Product Revenue87.9%
- US78.9%
- Disposable Product Revenue73.7%
- Product Revenue US70.4%
- Disposable Product Revenue US58.8%
- Capital Equipment Product Revenue14.2%
- Capital Equipment Product Revenue US11.7%
- Service Other8.2%
- Service Other US5.6%
- Lease Revenue Other3.1%
- Lease Revenue Other US2.5%
- Lease Revenue Capital Equipment0.9%
- Lease Revenue Capital Equipment US0.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product Revenue | $ 15 | 87.9% |
| US | $ 13 | 78.9% |
| Disposable Product Revenue | $ 12 | 73.7% |
10 more segments available
Sign in to unlock the full Vapotherm Inc dataset.
Description of Vapotherm Inc
Vapotherm Inc is a medical technology company that specializes in providing innovative respiratory care solutions for patients with breathing difficulties. The company was founded in 1993 and is headquartered in Exeter, New Hampshire, USA.
Vapotherm's core technology is called High Velocity Nasal Insufflation (HVNI), which is a form of non-invasive respiratory support. HVNI delivers heated and humidified high-flow respiratory gases directly into the patient's airways through nasal cannulas. This technology helps patients with various respiratory conditions breathe more comfortably and effectively, reducing the need for intubation or mechanical ventilation.
Vapotherm's respiratory support system is designed to address a wide range of patient needs, from premature infants in the neonatal intensive care unit (NICU) to adults in acute care settings. The system consists of a flow source, a heated and humidified disposable circuit, and a nasal cannula interface. The flow source delivers warmed and humidified air or medical oxygen at high flow rates to ensure optimal patient comfort and oxygenation.
One of the key advantages of Vapotherm's HVNI technology is its ability to deliver high flow rates of up to 40 liters per minute with precise temperature and humidity control. This helps to minimize discomfort and improve patient compliance compared to traditional oxygen therapy methods. The system also incorporates advanced algorithms and safety features to monitor and adjust the delivered flow according to the patient's needs.
Vapotherm's respiratory support system is widely used in hospitals, emergency departments, and long-term care facilities around the world. The technology has been clinically proven to be effective in managing respiratory distress in patients with conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory failure, asthma, and bronchiolitis.
In addition to their core technology, Vapotherm also offers a range of related products and accessories, including nasal cannulas of various sizes, circuits, filters, and humidification solutions. The company provides comprehensive training, support, and education programs to healthcare professionals to ensure safe and effective usage of their products.
Vapotherm is committed to ongoing research and development to further advance respiratory care solutions. They collaborate with leading medical institutions and experts to conduct clinical studies, publish research papers, and continuously improve their products. The company also holds a number of patents and trademarks related to their respiratory support system.
Overall, Vapotherm Inc is a global leader in providing innovative and effective respiratory care solutions. Their HVNI technology has revolutionized the way patients with respiratory distress are treated and has helped improve outcomes and quality of life for countless individuals.
Vapotherm's core technology is called High Velocity Nasal Insufflation (HVNI), which is a form of non-invasive respiratory support. HVNI delivers heated and humidified high-flow respiratory gases directly into the patient's airways through nasal cannulas. This technology helps patients with various respiratory conditions breathe more comfortably and effectively, reducing the need for intubation or mechanical ventilation.
Vapotherm's respiratory support system is designed to address a wide range of patient needs, from premature infants in the neonatal intensive care unit (NICU) to adults in acute care settings. The system consists of a flow source, a heated and humidified disposable circuit, and a nasal cannula interface. The flow source delivers warmed and humidified air or medical oxygen at high flow rates to ensure optimal patient comfort and oxygenation.
One of the key advantages of Vapotherm's HVNI technology is its ability to deliver high flow rates of up to 40 liters per minute with precise temperature and humidity control. This helps to minimize discomfort and improve patient compliance compared to traditional oxygen therapy methods. The system also incorporates advanced algorithms and safety features to monitor and adjust the delivered flow according to the patient's needs.
Vapotherm's respiratory support system is widely used in hospitals, emergency departments, and long-term care facilities around the world. The technology has been clinically proven to be effective in managing respiratory distress in patients with conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory failure, asthma, and bronchiolitis.
In addition to their core technology, Vapotherm also offers a range of related products and accessories, including nasal cannulas of various sizes, circuits, filters, and humidification solutions. The company provides comprehensive training, support, and education programs to healthcare professionals to ensure safe and effective usage of their products.
Vapotherm is committed to ongoing research and development to further advance respiratory care solutions. They collaborate with leading medical institutions and experts to conduct clinical studies, publish research papers, and continuously improve their products. The company also holds a number of patents and trademarks related to their respiratory support system.
Overall, Vapotherm Inc is a global leader in providing innovative and effective respiratory care solutions. Their HVNI technology has revolutionized the way patients with respiratory distress are treated and has helped improve outcomes and quality of life for countless individuals.
Vapotherm Inc. is a healthcare technology company specializing in innovative respiratory solutions that enhance the treatment and care of patients with respiratory distress, particularly in the management of conditions such as COVID-19, COPD, and other acute and chronic respiratory or respiratory-compromised patients. The companys primary focus is on high-velocity nasal insufflation (HVNI) therapy, which provides a non-invasive method of delivering respiratory support. Below are the extensive segments, products, and services that Vapotherm Inc. offers.
Product Segments
1. High-velocity Nasal Insufflation (HVNI) Systems
- Precision Flow® System: This is the flagship product of Vapotherm, designed to deliver heated and humidified oxygen through a nasal cannula at high flow rates. The Precision Flow system combines therapy modes that can be adjusted to the patients needs, offering versatility in acute care settings. This system is particularly valuable in treating patients with hypoxemia and providing respiratory support during and after surgical procedures.
2. Accessories and Disposables
- Nasal Cannulas: Vapotherm offers a range of specialized nasal cannulas designed for use with their Precision Flow systems, providing comfort and effective delivery of high-flow therapy.
- Heated and Humidified Circuitry: This includes various tubes and connectors designed to maintain optimal temperature and humidity levels for effective treatment, ensuring that patients receive the appropriate moisture content in their therapy.
3. Non-Invasive Positive Pressure Ventilation (NIPPV)
- The company provides integrated solutions that combine HVNI with non-invasive positive pressure ventilation, helping healthcare providers deliver comprehensive respiratory support to patients with varying degrees of respiratory distress.
4. Monitoring and Reporting Solutions
- Vapotherm incorporates data analytics and monitoring into their systems, providing real-time information about patient status and therapy effectiveness. This segment can include software platforms that aid clinicians in tracking patient progress and treatment outcomes.
Services Offered
1. Clinical Education and Training
- Vapotherm is committed to ensuring that healthcare professionals are well-trained in the use of their systems. They offer a range of educational programs, workshops, and on-site training that cover both the technical aspects of using their devices and the clinical applications of HVNI therapy.
2. Customer Support and Technical Assistance
- The company provides ongoing support for clinicians and healthcare facilities, including troubleshooting and technical assistance regarding the use of their devices. This support ensures that the equipment is used effectively and safely in clinical environments.
3. Research and Development Collaboration
- Vapotherm actively collaborates with clinical institutions and research organizations to advance knowledge in respiratory therapy and develop new technologies. This collaboration can lead to advancements in treatment protocols and further integration of their systems into clinical practice.
4. Patient Support Programs
- Vapotherm may offer programs aimed at patient education, helping individuals understand their respiratory conditions and how to use their therapy systems effectively. This can improve compliance and optimize treatment outcomes.
5. Integration Into Healthcare Solutions
- The company often works with healthcare systems to integrate their products seamlessly into existing workflows. This includes providing guidance on best practices for implementing HVNI therapy within emergency departments, intensive care units, and general hospital wards.
Target Markets
Vapotherm targets a variety of healthcare settings, including:
- Acute Care Hospitals: Where patients are often treated for critical respiratory conditions.
- Subacute Care Facilities: Including rehabilitation centers and skilled nursing facilities, where ongoing respiratory support may be needed.
- Home Healthcare: Offering solutions for patients requiring ongoing support outside of hospital settings.
- Specialty Clinics: Such as pulmonary and sleep clinics focusing on patients with chronic respiratory diseases.
Key Value Proposition
Vapotherms product offerings enable clinicians to provide non-invasive respiratory support that improves patient comfort while effectively managing respiratory distress. The combination of heating, humidification, and high flow rates reduces the potential complications associated with traditional oxygen therapy. Their technologies are designed to adapt to patient needs dynamically, making them suitable for a wide range of respiratory conditions in both adult and pediatric populations.
Overall, Vapotherm Inc. has positioned itself as a leader in the respiratory care space by focusing on advanced technology that enhances patient care and outcomes while delivering comprehensive support to healthcare providers.
Product Segments
1. High-velocity Nasal Insufflation (HVNI) Systems
- Precision Flow® System: This is the flagship product of Vapotherm, designed to deliver heated and humidified oxygen through a nasal cannula at high flow rates. The Precision Flow system combines therapy modes that can be adjusted to the patients needs, offering versatility in acute care settings. This system is particularly valuable in treating patients with hypoxemia and providing respiratory support during and after surgical procedures.
2. Accessories and Disposables
- Nasal Cannulas: Vapotherm offers a range of specialized nasal cannulas designed for use with their Precision Flow systems, providing comfort and effective delivery of high-flow therapy.
- Heated and Humidified Circuitry: This includes various tubes and connectors designed to maintain optimal temperature and humidity levels for effective treatment, ensuring that patients receive the appropriate moisture content in their therapy.
3. Non-Invasive Positive Pressure Ventilation (NIPPV)
- The company provides integrated solutions that combine HVNI with non-invasive positive pressure ventilation, helping healthcare providers deliver comprehensive respiratory support to patients with varying degrees of respiratory distress.
4. Monitoring and Reporting Solutions
- Vapotherm incorporates data analytics and monitoring into their systems, providing real-time information about patient status and therapy effectiveness. This segment can include software platforms that aid clinicians in tracking patient progress and treatment outcomes.
Services Offered
1. Clinical Education and Training
- Vapotherm is committed to ensuring that healthcare professionals are well-trained in the use of their systems. They offer a range of educational programs, workshops, and on-site training that cover both the technical aspects of using their devices and the clinical applications of HVNI therapy.
2. Customer Support and Technical Assistance
- The company provides ongoing support for clinicians and healthcare facilities, including troubleshooting and technical assistance regarding the use of their devices. This support ensures that the equipment is used effectively and safely in clinical environments.
3. Research and Development Collaboration
- Vapotherm actively collaborates with clinical institutions and research organizations to advance knowledge in respiratory therapy and develop new technologies. This collaboration can lead to advancements in treatment protocols and further integration of their systems into clinical practice.
4. Patient Support Programs
- Vapotherm may offer programs aimed at patient education, helping individuals understand their respiratory conditions and how to use their therapy systems effectively. This can improve compliance and optimize treatment outcomes.
5. Integration Into Healthcare Solutions
- The company often works with healthcare systems to integrate their products seamlessly into existing workflows. This includes providing guidance on best practices for implementing HVNI therapy within emergency departments, intensive care units, and general hospital wards.
Target Markets
Vapotherm targets a variety of healthcare settings, including:
- Acute Care Hospitals: Where patients are often treated for critical respiratory conditions.
- Subacute Care Facilities: Including rehabilitation centers and skilled nursing facilities, where ongoing respiratory support may be needed.
- Home Healthcare: Offering solutions for patients requiring ongoing support outside of hospital settings.
- Specialty Clinics: Such as pulmonary and sleep clinics focusing on patients with chronic respiratory diseases.
Key Value Proposition
Vapotherms product offerings enable clinicians to provide non-invasive respiratory support that improves patient comfort while effectively managing respiratory distress. The combination of heating, humidification, and high flow rates reduces the potential complications associated with traditional oxygen therapy. Their technologies are designed to adapt to patient needs dynamically, making them suitable for a wide range of respiratory conditions in both adult and pediatric populations.
Overall, Vapotherm Inc. has positioned itself as a leader in the respiratory care space by focusing on advanced technology that enhances patient care and outcomes while delivering comprehensive support to healthcare providers.
